Singulair
Merck: ‘2014 revenues will be down’
February 7, 2014Sales and Marketing Frazier, Merck, Simponi, Singulair, isentress, q4, results
Merck is the latest pharma company to release figures suggesting 2013 was more of a struggle than it would like, …
Merck sees sales dip
July 31, 2013Sales and Marketing Merck, Q2, Singulair, sales
A catastrophic decline in sales of asthma medicine Singulair is among the key reasons why Merck’s pharma revenue fell 12% …
Merck’s Singulair faces generic rivals
August 7, 2012Sales and Marketing Merck, Singulair, generic erosion, patent
Merck has lost patent protection on its biggest selling drug Singulair, opening the floodgates for generic rivals. Merck’s drug brought …
Merck sees growth in second quarter
July 30, 2012Sales and Marketing Cozaar, Merck, Q2, Singulair
Merck has posted a healthy sales increase for the second quarter, as its established drugs grew strongly. Sales increased 1% …
Merck posts strong results for 2011
February 2, 2012Sales and Marketing Frazier, Merck, Singulair, Victrelis
Foreign exchange rates and strong sales from established products helped Merck to achieve single-digit growth for 2011. The US firm …
